Simpson Dene, Wellington Keri
Adis International Limited, Auckland, New Zealand.
Drugs. 2004;64(17):1941-55. doi: 10.2165/00003495-200464170-00012.
Nicorandil (Adancor, Angicor, Dancor, Nikoril [Europe], Ikorel [Europe and Oceania], Sigmart [Japan, Korea and Taiwan]) is an adenosine triphosphate (ATP)-sensitive potassium (KATP) channel agonist with nitrate-like properties used in the management of stable angina pectoris. With well established monotherapeutic antianginal activity and a beneficial effect (when added to optimal antianginal therapy) on clinical outcomes in high-risk patients with stable angina, twice-daily oral nicorandil is a useful alternative or addition to other antianginal therapy.
尼可地尔（Adancor、Angicor、Dancor、Nikoril[欧洲]、Ikorel[欧洲和大洋洲]、Sigmart[日本、韩国和台湾]）是一种具有硝酸盐样特性的三磷酸腺苷（ATP）敏感性钾（KATP）通道激动剂，用于治疗稳定型心绞痛。尼可地尔每日口服两次，具有明确的单一抗心绞痛活性，且（添加至最佳抗心绞痛治疗方案时）对稳定型心绞痛高危患者的临床结局有有益影响，是其他抗心绞痛治疗的有用替代药物或补充药物。
